Copyright Reports & Markets. All rights reserved.

Global Addison's Disease Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Addison's Disease Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Oral Corticosteroid
      • 1.4.3 Corticosteroid Injections
    • 1.5 Market by Application
      • 1.5.1 Global Addison's Disease Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Addison's Disease Treatment Market Size
    • 2.2 Addison's Disease Treatment Growth Trends by Regions
      • 2.2.1 Addison's Disease Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Addison's Disease Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Addison's Disease Treatment Market Size by Manufacturers
      • 3.1.1 Global Addison's Disease Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Addison's Disease Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Addison's Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Addison's Disease Treatment Key Players Head office and Area Served
    • 3.3 Key Players Addison's Disease Treatment Product/Solution/Service
    • 3.4 Date of Enter into Addison's Disease Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Addison's Disease Treatment Market Size by Type (2014-2019)
    • 4.2 Global Addison's Disease Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Addison's Disease Treatment Market Size (2014-2019)
    • 5.2 Addison's Disease Treatment Key Players in United States
    • 5.3 United States Addison's Disease Treatment Market Size by Type
    • 5.4 United States Addison's Disease Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Addison's Disease Treatment Market Size (2014-2019)
    • 6.2 Addison's Disease Treatment Key Players in Europe
    • 6.3 Europe Addison's Disease Treatment Market Size by Type
    • 6.4 Europe Addison's Disease Treatment Market Size by Application

    7 China

    • 7.1 China Addison's Disease Treatment Market Size (2014-2019)
    • 7.2 Addison's Disease Treatment Key Players in China
    • 7.3 China Addison's Disease Treatment Market Size by Type
    • 7.4 China Addison's Disease Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Addison's Disease Treatment Market Size (2014-2019)
    • 8.2 Addison's Disease Treatment Key Players in Japan
    • 8.3 Japan Addison's Disease Treatment Market Size by Type
    • 8.4 Japan Addison's Disease Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Addison's Disease Treatment Market Size (2014-2019)
    • 9.2 Addison's Disease Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Addison's Disease Treatment Market Size by Type
    • 9.4 Southeast Asia Addison's Disease Treatment Market Size by Application

    10 India

    • 10.1 India Addison's Disease Treatment Market Size (2014-2019)
    • 10.2 Addison's Disease Treatment Key Players in India
    • 10.3 India Addison's Disease Treatment Market Size by Type
    • 10.4 India Addison's Disease Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Addison's Disease Treatment Market Size (2014-2019)
    • 11.2 Addison's Disease Treatment Key Players in Central & South America
    • 11.3 Central & South America Addison's Disease Treatment Market Size by Type
    • 11.4 Central & South America Addison's Disease Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Addison's Disease Treatment Introduction
      • 12.1.4 Pfizer Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 GlaxoSmithKline
      • 12.2.1 GlaxoSmithKline Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Addison's Disease Treatment Introduction
      • 12.2.4 GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Recent Development
    • 12.3 Shire
      • 12.3.1 Shire Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Addison's Disease Treatment Introduction
      • 12.3.4 Shire Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.3.5 Shire Recent Development
    • 12.4 Abbott Laboratories
      • 12.4.1 Abbott Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Addison's Disease Treatment Introduction
      • 12.4.4 Abbott Laboratories Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.4.5 Abbott Laboratories Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Addison's Disease Treatment Introduction
      • 12.5.4 Merck Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Boehringer Ingelheim
      • 12.6.1 Boehringer Ingelheim Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Addison's Disease Treatment Introduction
      • 12.6.4 Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.6.5 Boehringer Ingelheim Recent Development
    • 12.7 Amgen
      • 12.7.1 Amgen Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Addison's Disease Treatment Introduction
      • 12.7.4 Amgen Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.7.5 Amgen Recent Development
    • 12.8 Lupin Pharmaceuticals
      • 12.8.1 Lupin Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Addison's Disease Treatment Introduction
      • 12.8.4 Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2014-2019)
      • 12.8.5 Lupin Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.
      In 2018, the global Addison's Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Addison's Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Addison's Disease Treatment development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      GlaxoSmithKline
      Shire
      Abbott Laboratories
      Merck
      Boehringer Ingelheim
      Amgen
      Lupin Pharmaceuticals

      Market segment by Type, the product can be split into
      Oral Corticosteroid
      Corticosteroid Injections

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Addison's Disease Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Addison's Disease Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Addison's Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now